Vilacto Bio Stock

Vilacto Bio ROE

Delisted

The Return on Equity (ROE) of Vilacto Bio (VIBI) as of Aug 16, 2026 is 200.25 %. In the previous year, Return on Equity (ROE) was 95.43 % — a change of 109.85% (higher).

ROE

200.25 %

YoY

109.85%

Last updated:

In 2026, Vilacto Bio's return on equity (ROE) was 200.25 %, a 109.85% increase from the 95.43 % ROE in the previous year.

Access this data via the Eulerpool API

Vilacto Bio Stock analysis

What does Vilacto Bio do? Vilacto Bio Inc is a company that was founded in the USA in 2014. It was founded with the goal of producing natural and high-quality skincare products that support skin health and behave environmentally and ethically responsibly. The history of Vilacto Bio began when the CEO and founder of the company, Allan Villadsen, started his company with the production of concentrate products for cosmetics. The company was based on his research and discovery of a previously unknown ingredient, namely Lactoactive. This miracle substance could help in the treatment of skin conditions such as acne, psoriasis, and eczema. Vilacto Bio's products quickly experienced success and were praised by many customers and skincare experts worldwide. Vilacto Bio offers a variety of skincare products, including face creams, face masks, hand creams, body butter, body oils, and lip balms. The company uses only natural ingredients such as aloe vera, propolis, and shea butter to ensure that their products are as gentle as possible on the skin. Vilacto Bio's skincare products are divided into three different lines - Vilacto Premium Line, Vilacto Medi+ Line, and Vilacto Baby & Kids Line. Vilacto Premium Line is intended for people looking for high-quality and luxurious skincare products. Vilacto Medi+ Line is particularly suitable for people suffering from skin conditions such as psoriasis. Vilacto Baby & Kids Line, on the other hand, is suitable for the delicate and sensitive skin of children and babies. Vilacto Bio's business model is based on the principles of sustainability and ethical production. The company is committed to producing its products in an environmentally friendly manner and is committed to considering social and environmental conditions in every production. Vilacto Bio demonstrates this through careful selection of suppliers, raw materials, and packaging. The company's goal is to produce products that are not only good for the skin but also good for the environment and society as a whole. Overall, Vilacto Bio is a company dedicated to the production of natural and skin-friendly cosmetic products. They are passionate, committed, and strive to produce the best possible products for their customers. They believe in sustainability, ethical practices, and global responsibility, and demonstrate this in every aspect of their product manufacturing. Through their ability to combine natural skincare products with innovative formulas and sustainability, they are making a name for themselves as a leading skincare manufacturer worldwide. Vilacto Bio is one of the most popular companies on Eulerpool.

ROE Details

Decoding Vilacto Bio's Return on Equity (ROE)

Vilacto Bio's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Vilacto Bio's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Vilacto Bio's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Vilacto Bio’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Vilacto Bio stock

Return on Equity (ROE) of Vilacto Bio is 200.25 % in 2026.

Return on Equity (ROE) of Vilacto Bio changed from 95.43 % to 200.25 %, representing a 109.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Vilacto Bio since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Vilacto Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Vilacto Bio

All Key Metrics — Vilacto Bio